Fundraising FoxOrganOx
Oxford, GB · 9 known investors
Find your way into OrganOx
Sign up to see every warm intro you have to OrganOx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OrganOx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OrganOx develops the metra platform, a device that extends organ preservation time for liver transplants by maintaining continuous perfusion with oxygenated blood-based solutions, enabling surgeons to better assess organ viability and make more informed transplant decisions.
Founders & leadership
Investors · 9
How we know: Amadeus Capital Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Business Growth Fund's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: HealthQuest Capital's portfolio page · a partner's Signal profile · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Lauxera Capital Partners's portfolio page · funding news · globenewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountgrowth roundJul 2023
Lauxera Capital Partners (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
5 people who came through OrganOx went on to found or lead other companies.
Companies House · registry record
View on Companies House ↗- Registered name
- ORGANOX LIMITED
- Company number
- 06557113
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 7 Apr 2008
- Registered office
- 125 Wood Street, London, EC2V 7AW
- Nature of business (SIC)
- 72190 — Other research and experimental development on natural sciences and engineering
- Accounts
- last made up to 31 Dec 2024 · next due 31 Dec 2026
- Confirmation statement
- last made up to 7 Apr 2026 · next due 21 Apr 2027
Current officers · 6
- Annabel Andrew — secretary, appointed 1 May 2025
- Jin Hagimoto — director, appointed 29 Oct 2025
- Takuya Hosokai — director, appointed 29 Oct 2025
- Naoya Iwata — director, appointed 1 Jun 2026
- Norimasa Kunimoto — director, appointed 29 Oct 2025
- Bhawna Menghnani — director, appointed 1 Apr 2026
Source: Companies House public register · retrieved 13 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does OrganOx do?
- OrganOx develops the metra platform, a device that extends organ preservation time for liver transplants by maintaining continuous perfusion with oxygenated blood-based solutions, enabling surgeons to better assess organ viability and make more informed transplant decisions.
- Who founded OrganOx?
- OrganOx was founded by Prof. Peter Friend.
- Who are OrganOx's investors?
- OrganOx's investors include Amadeus Capital Partners, Anjost, Business Growth Fund, HealthQuest Capital, Intuitive Ventures, Lauxera Capital Partners, Longwall Venture Partners LLP, Oxford University Innovation and 1 more.
- Where is OrganOx headquartered?
- OrganOx is headquartered in Oxford, GB.